Corporate News 10-Aug-22
Board of Natco Pharma recommends Interim Dividend
Of Rs.3.50 per share
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 09 August 2022, has recommended a Interim dividend of Rs.3.50 per share (i.e.175%), subject to the approval of the shareholders.
Previous News
Natco Pharma spurts as Q1 PAT climbs 59% YoY to Rs 668 cr
( Hot Pursuit - 12-Aug-24 15:13 )
Natco Pharma Ltd soars 1.44%
( Hot Pursuit - 17-Jul-23 13:05 )
Board of Natco Pharma recommends dividend
( Corporate News - 12-Aug-24 15:57 )
Natco Pharma Ltd spurts 1.44%, gains for five straight sessions
( Hot Pursuit - 09-Aug-23 13:00 )
Natco Pharma announces demise of director
( Corporate News - 31-Jul-24 11:56 )
Natco Pharma consolidated net profit rises 59.05% in the June 2024 quarter
( Results - Announcements 12-Aug-24 15:07 )
Natco Pharma fixes record date for interim dividend
( Market Beat - Reports 09-Aug-23 15:22 )
Natco Pharma launches Pomalidomide Capsules in Canada
( Corporate News - 01-Mar-23 09:26 )
Natco Pharma Ltd extends losing spree
( Hot Pursuit - 24-Mar-22 13:35 )
Natco Pharma Ltd gains for fifth session
( Hot Pursuit - 04-Oct-21 13:00 )
Natco Pharma launches generic Pomalidomide capsules in Canada
( Hot Pursuit - 01-Mar-23 09:24 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
